FAILURE OF NON-17-ALKYLATED ANABOLIC STEROIDS TO PRODUCE ABNORMAL LIVER FUNCTION TESTS

被引:17
作者
MARQUARDT, GH
LOGAN, CE
TOMHAVE, WG
DOWBEN, RM
机构
关键词
D O I
10.1210/jcem-24-12-1334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1334 / +
相关论文
共 13 条
[1]  
DOUNCE AL, 1950, J BIOL CHEM, V185, P769
[2]  
DOWBEN RM, 1959, J LAB CLIN MED, V54, P867
[3]  
KOLB KH, 1962, ARZNEIMITTEL-FORSCH, V12, P228
[4]   A 6-MONTH EVALUATION OF AN ANABOLIC DRUG, NORETHANDROLONE, IN UNDERWEIGHT PERSONS .2. BROMSULPHALEIN (BSP) RETENTION AND LIVER FUNCTION [J].
KORY, RC ;
BRADLEY, MH ;
WATSON, RN ;
CALLAHAN, R ;
PETERS, BJ .
AMERICAN JOURNAL OF MEDICINE, 1959, 26 (02) :243-248
[5]  
MARGUARDT GH, 1961, JAMA-J AM MED ASSOC, V175, P851
[6]  
MEISTER A, 1950, J BIOL CHEM, V184, P117
[7]  
NORYMBERSKI JK, 1953, LANCET, V1, P1276
[8]   NOR-ANDROSTENOLONEPHENYLPROPIONATE, A NEW POTENT ANABOLIC ESTER [J].
OVERBEEK, GA ;
DEVISSER, J .
ACTA ENDOCRINOLOGICA, 1957, 24 (02) :209-219
[9]   CHOLESTASIS PRODUCED BY THE ADMINISTRATION OF NORETHANDROLONE [J].
SCHAFFNER, F ;
POPPER, H ;
CHESROW, E .
AMERICAN JOURNAL OF MEDICINE, 1959, 26 (02) :249-254
[10]  
SUCHOWSKY GK, 1961, KLIN WOCHENSCHR, V7, P369